Improving pharmacy and therapeutics committee operations.
A panel discussion of various aspects of the operations of pharmacy and therapeutics (P & T) committees is presented. Pharmacy and therapeutics committee operations in various types and sizes of hospitals are described. Ways of stimulating physicians' interest in P & T committee activities, difficult problems faced, scope of issues dealt with by P & T committees, functions of P & T subcommittees, the value of drug information from pharmaceutical representatives, and the influence of research funds from the pharmaceutical industry on committee decisions are discussed. Panel members also present their views on therapeutic alternates, FDA-nonapproved use of drugs, and counter-detailing. Finally, suggestions for improving P & T drug evaluations, cost-containment issues, and the authority of P & T committees are discussed. A well-prepared agenda, good educational material, active members, and strong leadership are important for successful P & T committee operations.
D000329:Advertising; D004341:Drug Evaluation; D004345:Drug Industry; D005572:Formularies, Hospital as Topic / Q000191:economics; D006801:Humans; D010607:Pharmacy Service, Hospital / Q000191:economics / Q000458:organization & administration / Q000592:standards; D010606:Pharmacy and Therapeutics Committee / Q000191:economics / Q000458:organization & administration*; D010819:Physician's Role; D014481:United States; D014486:United States Food and Drug Administration